1,238
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prevalence, Antibiotic Susceptibility Profile and Associated Factors of Group A Streptococcal pharyngitis Among Pediatric Patients with Acute Pharyngitis in Gondar, Northwest Ethiopia

, ORCID Icon, ORCID Icon, &
Pages 1637-1648 | Received 22 Dec 2022, Accepted 16 Mar 2023, Published online: 22 Mar 2023

References

  • Sidrah K, Pradeep V. Streptococcus Pyogenes - StatPearls - NCBI Bookshelf. Stat Pearls; 2022.
  • Lancefield RC. A micro precipitin-technic for classifying hemolytic streptococci, and improved methods for producing antisera. Proc Soc Exp Biol Med. 1938;38:4.
  • Arnold JC, Nizet V. Pharyngitis. In: Long SS, Proper CG, Fischer M, editors. Principles and Practice of Pediatric Infectious Diseases. Elsevier; 2018.
  • Jasim SA, Hatem ZA, Mohammed ZA. Virulence factors and clinical features of Streptococcus pyogenes: overview. Ann Rom Soc Cell Biol. 2021;25:1.
  • Terao Y. The virulence factors and pathogenic mechanisms of Streptococcus pyogenes. J Oral Biosci. 2012;54(2):96–100.
  • Darenberg J, Henriques-Normark B, Lepp T, Tegmark-Wisell K, Tegnell A, Widgren K. Increased incidence of invasive group A streptococcal infections in Sweden, January 2012–February 2013. Eurosurveillance. 2013;18:14.
  • Ibrahim J, Eisen JA, Jospin G, Coil DA, Khazen G, Tokajian S. Genome analysis of Streptococcus pyogenes associated with pharyngitis and skin infections. PLoS One. 2016;11(12):e0168177.
  • Bennett JE, Dolin R, Blaser MJ, editors, Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Philadelphia, PA: Elsevier; 2020:5407.
  • Wessels MR. Streptococcal Pharyngitis. N Engl J Med. 2011;364(7):648–655.
  • Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev. 2000;13(3):470–511.
  • Ashurst JV, Edgerley-Gibb L. Streptococcal Pharyngitis. N Eng J Med. 2011;364(7):648–655.
  • Renner B, Mueller CA, Shephard A. Environmental and non-infectious factors in the aetiology of pharyngitis (sore throat). Inflamm Res. 2012;61(10):1041–1052.
  • Olafsdottir LB, Erlendsdóttir H, Melo-Cristino J, et al. Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012. Eurosurveillance. 2014;19:17.
  • Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group a streptococcal pharyngitis: 2012 update by the infectious diseases society of America. Clin Infect Dis. 2012;55(10):e86–102.
  • Gunnarsson RK, Holm SE, Söderström M. The prevalence of beta-haemolytic streptococci in throat specimens from healthy children and adults: implications for the clinical value of throat cultures. Scand J Prim Health Care. 1997;15(3):149–155.
  • Al-Hasnawi EAF, Abbas OK, Al-Taie W. Detection and evaluation of Streptococcus pyogenes (group A) as a superior infectious agent of acute pharyngitis among school age children. Ann Trop Med Public Heal. 2020;23(7):562–569.
  • Ferretti JJ, Stevens DL, Fischetti VA, editors. Streptococcus Pyogenes: Basic Biology to Clinical Manifestations. University of Oklahoma Health Sciences Center; 2016:467–476.
  • Wolford RW, Goyal A, Belgam Syed SY, Schaefer TJ. Pharyngitis. StatPearls; 2022.
  • Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–694.
  • Miller KM, Carapetis JR, Van Beneden CA, et al. The global burden of sore throat and group A Streptococcus pharyngitis: a systematic review and meta-analysis. eClinicalMedicine. 2022;48:101458.
  • Ryan ET, Hill DR, Solomon T, Aronson NE, Endy TP. Hunter’s Tropical Medicine and Emerging Infectious Disease. 9th ed. Ryan ET; 2020:429–438 p.
  • Bennett J, Moreland NJ, Zhang J, et al. Risk factors for group A streptococcal pharyngitis and skin infections: a case control study. Lancet Reg Heal. 2022;26:100507.
  • Avire NJ, Whiley H, Ross K. A review of Streptococcus pyogenes: public health risk factors, prevention and control. Pathogens. 2021;10(2):248.
  • Good MF. Streptococcus: an organism causing diseases beyond neglect. PLoS Negl Trop Dis. 2020;14(5):e0008095.
  • Gemechu T, Mahmoud H, Parry EH, Phillips DI, Yacoub MH. Community-based prevalence study of rheumatic heart disease in rural Ethiopia. Eur J Prev Cardiol. 2017;24(7):717–723.
  • Martin JM. Pharyngitis and streptococcal throat infections. Pediatr Ann. 2010;39:1.
  • Gunnarsson MS, Sundvall PD, Gunnarsson R. In primary health care, never prescribe antibiotics to patients suspected of having an uncomplicated sore throat caused by group A beta-haemolytic streptococci without first confirming the presence of this bacterium. Scand J Infect Dis. 2012;44(12):915–921.
  • McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287(23):3096.
  • Pfaller MA, Carvalhaes CG, Smith CJ, Diekema DJ, Castanheira M. Bacterial and fungal pathogens isolated from patients with bloodstream infection: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (2012–2017). Diagn Microbiol Infect Dis. 2020;97(2):115016.
  • Barsenga S, Mitiku H, Tesfa T, Shume T. Throat carriage rate, associated factors, and antimicrobial susceptibility pattern of group A Streptococcus among healthy school children in Jigjiga City, Eastern Ethiopia. BMC Pediatr. 2022;22(1):227.
  • Kebede D, Admas A, Mekonnen D. Prevalence and antibiotics susceptibility profiles of Streptococcus pyogenes among pediatric patients with acute pharyngitis at Felege Hiwot Comprehensive Specialized Hospital, Northwest Ethiopia. BMC Microbiol. 2021;21(1):135.
  • Magiorakos A-P, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
  • Flores AR, Caserta MT. Pharyngitis. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Elsevier; 2015:753–759.e2.
  • McDonald M, Towers R, Fagan P, et al. Recovering streptococci from the throat, a practical alternative to direct plating in remote tropical communities. J Clin Microbiol. 2006;44(2):547–552.
  • World Health Organization. Guidelines for the Collection of Clinical Specimens During Field Investigation of Outbreaks. World Health Organization; 2000.
  • Cheesbrough M. District Laboratory Practice in Tropical Countries: Part 2. 2nd ed. New York: Cambridge University Press; 2006:76–79.
  • CLSI. Performance Standards for Antimicrobial Susceptibility Testing: CLSI Supplement M100. 31st ed. Clinical and Laboratory Standards Institute; 2021.
  • Basu S, Pal A, Desai P. Quality control of culture media in a microbiology laboratory. Indian J Med Microbiol. 2005;23(3):159.
  • Ahmed M, Hassan M, Eida M, Metwally L. Evaluation of appropriateness of antibiotic use and validation of the McIsaac-modified Centor score for group a beta hemolytic streptococcal acute pharyngitis in Suez Canal area. Suez Canal Univ Med J. 2015;18(2):117–124.
  • Mustafa Z, Ghaffari M. Diagnostic methods, clinical guidelines, and antibiotic treatment for group a Streptococcal pharyngitis: a narrative review. Front Cell Infect Microbiol. 2020;15:10.
  • Tesfaw G, Kibru G, Mekonnen D, Abdissa A. Prevalence of group A β-haemolytic Streptococcus among children with pharyngitis in Jimma town, Southwest Ethiopia. Egypt J Ear Nose Throat Allied Sci. 2015;16(1):35–40.
  • Altun M, Mericli Yapıcı B. Detection of group a beta hemolytic streptococci species, emm, and exotoxin genes isolated from patients with tonsillopharyngitis. Curr Microbiol. 2020;77(9):2064–2070.
  • Malino IY, Utama DL, Soenarto Y. McIsaac criteria for diagnosis of acute group-A β-hemolytic streptococcal pharyngitis. Paediatr Indones. 2016;53(5):258.
  • Benouda A, Sibile S, Ziane Y, Elouennass M, Dahani K, Hassani A. Place de Streptococcus pyogenes dans les angines au Maroc et état actuel de sa sensibilité aux antibiotiques. Pathol Biol. 2009;57(1):76–80.
  • Sherkatolabbasieh H, Firouzi M, Shafizadeh S, Amiri I. Antibiotic susceptibility evaluation of bacterial agents causing infection in children with acute tonsillopharyngitis. Infect Disord. 2021;21:6.
  • Himri S, Oumokhtar B, Atmani S, et al. Prevalence of group a streptococci in Moroccan children with pharyngitis and emm type distribution. Arch Pediatr Infect Dis. 2021;9:4.
  • Khandekar A, Dangre-Mudey G. Tackling rheumatic heart disease: prevalence and antibiogram of Streptococcus pyogenes in cases of paediatric pharyngitis. J Clin Diagn Res. 2019;2019:1.
  • Bobia AA, Blaj OA, Oancea D, et al. The prevalence of beta hemolytic Streptococcus in a children’s tertiary care hospital in Timisoara. Cent Eur J Clin Res. 2019;2(1):73–78.
  • Kumar R, Vohra H, Chakraborty A, et al. Epidemiology of group a streptococcal pharyngitis & impetigo: a cross-sectional & follow up study in a rural community of northern India. Indian J Med Res. 2009;130:6.
  • Khosravi AD, Ebrahimifard N, Shamsizadeh A, Shoja S. Isolation of Streptococcus pyogenes from children with pharyngitis and emm type analysis. J Chin Med Assoc. 2016;79(5):276–280.
  • Rathi SK, Ahmed R. Pakistan prevalence survey in acute pharyngitis. J Pak Med Assoc. 2014;64:8.
  • Bhalla K, Bhardwaj P, Gupta A, Mehra S, Nehra D, Nanda S. Role of epidemiological risk factors in improving the clinical diagnosis of streptococcal sore throat in pediatric clinical practice. J Fam Med Prim Care. 2019;8(10):3130.
  • Sayyahfar S, Fahimzad A, Naddaf A, Tavassoli S. Antibiotic susceptibility evaluation of group a Streptococcus isolated from children with pharyngitis: a study from Iran. Infect Chemother. 2015;47(4):225.
  • Ba-Saddik IA, Munibari AA, Alhilali AM, et al. Prevalence of Group A beta-haemolytic Streptococcus isolated from children with acute pharyngotonsillitis in Aden, Yemen. Trop Med Int Heal. 2014;19(4):431–439.
  • Coffey PM, Ralph AP, Krause VL. The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: a systematic review. PLoS Negl Trop Dis. 2018;12(6):e0006577.
  • Shaikh N, Leonard E, Martin JM. Prevalence of streptococcal pharyngitis and streptococcal carriage in children: a meta-analysis. Pediatrics. 2010;126(3):e557–64.
  • Falagas ME, Mourtzoukou EG, Vardakas KZ. Sex differences in the incidence and severity of respiratory tract infections. Respir Med. 2007;101(9):1845–1863.
  • Jo SA, Ma SH, Kim S. Diagnostic impact of clinical manifestations of group A Streptococcal pharyngitis. Infect Chemother. 2021;53(3):553.
  • Palla AH, Khan RA, Gilani AH, Marra F. Over prescription of antibiotics for adult pharyngitis is prevalent in developing countries but can be reduced using McIsaac modification of Centor scores: a cross-sectional study. BMC Pulm Med. 2012;12(1):70.
  • Smeesters PR, Campos D, Van Melderen L, de Aguiar E, Vanderpas J, Vergison A. Pharyngitis in low-resources settings: a pragmatic clinical approach to reduce unnecessary antibiotic use. Pediatrics. 2006;118(6):e1607–11.
  • Teng CL, Tong SF, Khoo EM, et al. Antibiotics for URTI and UTI – prescribing in Malaysian primary care settings. Aust Fam Physician. 2011;40(5):325–329.
  • Regoli M, Chiappini E, Bonsignori F, Galli L, de Martino M. Update on the management of acute pharyngitis in children. Ital J Pediatr. 2011;37(1):10.
  • Pichichero ME, Casey JR. Safe use of selected cephalosporins in penicillin‐allergic patients: a meta‐analysis. Otolaryngol Neck Surg. 2007;136(3):340–347.
  • Romano A, Valluzzi RL, Caruso C, Maggioletti M, Quaratino D, Gaeta F. Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol Pract. 2018;6(5):1662–1672.
  • Chuang P-K, Wang S-M, Lin H-C, et al. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan. J Microbiol Immunol Infect. 2015;48(2):160–167.
  • Tsai W-C, Shen C-F, Lin Y-L, et al. Emergence of macrolide-resistant Streptococcus pyogenes emm12 in southern Taiwan from 2000 to 2019. J Microbiol Immunol Infect. 2021;54(6):1086–1093.
  • Silva-Costa C, Friães A, Ramirez M, Melo-Cristino J. Macrolide-resistant Streptococcus pyogenes: prevalence and treatment strategies. Expert Rev Anti Infect Ther. 2015;13(5):615–628.
  • DeMuri GP, Sterkel AK, Kubica PA, Duster MN, Reed KD, Wald ER. Macrolide and clindamycin resistance in group A streptococci isolated from children with pharyngitis. Pediatr Infect Dis J. 2017;36(3):342–344.
  • Leclercq R, Courvalin P. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob Agents Chemother. 1991;35:1.
  • Creti R, Imperi M, Baldassarri L, et al. Types, virulence factors, and antibiotic resistance of invasive Streptococcus pyogenes isolates from Italy: what has changed in 11 years? J Clin Microbiol. 2007;45(7):2249–2256.
  • Anja A, Beyene G, Mariam Z, Daka D. Asymptomatic pharyngeal carriage rate of Streptococcus pyogenes, its associated factors and antibiotic susceptibility pattern among school children in Hawassa town, southern Ethiopia. BMC Res Notes. 2019;12(1):564.
  • Kehrenberg C, Schwarz S, Jacobsen L, Hansen LH, Vester B. A new mechanism for chloramphenicol, florfenicol and clindamycin resistance: methylation of 23S ribosomal RNA at A2503. Mol Microbiol. 2005;57(4):1064–1073.
  • Schwarz S, Kehrenberg C, Doublet B, Cloeckaert A. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev. 2004;28(5):519–542.
  • Oong GC, Tadi P. Chloramphenicol. In: StatPearls. StatPearls Publishing; 2022.
  • Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232–260.
  • Belachew SA, Hall L, Selvey LA. Non-prescription dispensing of antibiotic agents among community drug retail outlets in Sub-Saharan African countries: a systematic review and meta-analysis. Antimicrob Resist Infect Control. 2021;10(1):13.
  • World Medical Association. Declaration of Helsinki. JAMA. 2013;310(20):2191.